| Changes in buprenorphine-naloxone and opioid pain reliever prescriptions after the Affordable Care Act Medicaid expansion B Saloner, J Levin, HY Chang, C Jones, GC Alexander JAMA network open 1 (4), e181588-e181588, 2018 | 126 | 2018 |
| News media reporting on medication treatment for opioid use disorder amid the opioid epidemic A Kennedy-Hendricks, J Levin, E Stone, EE McGinty, SE Gollust, CL Barry Health Affairs 38 (4), 643-651, 2019 | 52 | 2019 |
| Community Health Centers and Access to Care Among Underserved Populations: A Synthesis Review B Saloner, AS Wilk, J Levin Medical Care Research and Review 77 (1), 3-18, 2020 | 41 | 2020 |
| Sociodemographic differences in quality of treatment to Medicaid enrollees receiving buprenorphine RK Landis, JS Levin, B Saloner, AJ Gordon, AW Dick, TB Sherry, ... Substance Abuse 43 (1), 1057-1071, 2022 | 18 | 2022 |
| Does Incorporating Cost-Effectiveness Analysis Into Prescribing Decisions Promote Drug Access Equity? MJ DiStefano, JS Levin AMA Journal of Ethics 21 (8), 679-685, 2019 | 10 | 2019 |
| Cost-effectiveness of total state coverage for hepatitis C medications WV Padula, JS Levin, J Lee, GF Anderson Am J Manag Care 27 (5), e171-e177, 2021 | 7 | 2021 |
| Assessing Relationships Between Drug Shortages in the United States and Other Countries AW Mulcahy, P Rao, V Kareddy, DM Agniel, JS Levin, D Schwam RAND, 2021 | 7 | 2021 |
| Differences in buprenorphine treatment quality across physician provider specialties JS Levin, RK Landis, M Sorbero, AW Dick, B Saloner, BD Stein Drug and Alcohol Dependence, 109510, 2022 | 5 | 2022 |
| Carve-In Models for Specialty Behavioral Health Services in Medicaid M Horvitz-Lennon, JS Levin, J Breslau, J Kushner, NK Eberhart, ... RAND, 2022 | 5 | 2022 |
| Use and cost of disease-modifying therapies by Sonya Slifka Study participants: has anything really changed since 2000 and 2009? SL Minden, RP Kinkel, HT Machado, JS Levin, MB Rosenthal, LI Iezzoni Multiple Sclerosis Journal–Experimental, Translational and Clinical 5 (1 …, 2019 | 5 | 2019 |
| Is Carve-In Financing Of Medicaid Behavioral Health Services Better Than Carve-Out? M Horvitz-Lennon, KJ McConnell, S Glied, JS Levin, NK Eberhart, ... Health Affairs Forefront, 2023 | 3 | 2023 |
| New prescription fills of selective serotonin reuptake inhibitors before and during the COVID-19 pandemic in Los Angeles County, California JS Levin, J Acosta, LJ Faherty Journal of affective disorders 319, 507-510, 2022 | 3 | 2022 |
| Association Between Hospital‐Physician Vertical Integration and Medication Adherence Rates JS Levin, S Komanduri, C Whaley Health Services Research, 2022 | 2 | 2022 |
| Consolidated Drug Purchasing Across Federal Agencies: A Policy to Decrease Cost Sharing for Medicare Beneficiaries J Levin Journal of Health Care Finance, 2019 | 2 | 2019 |
| Financial Interventions to Improve Screening in Primary Care: A Systematic Review S Matthews, N Qureshi, JS Levin, NK Eberhart, J Breslau, RK McBain American Journal of Preventive Medicine, 2024 | 1 | 2024 |
| The effect of adverse childhood experience training, screening, and response in primary care: a systematic review RK McBain, JS Levin, S Matthews, N Qureshi, D Long, AB Schickedanz, ... eClinicalMedicine 65, 2023 | 1 | 2023 |
| Are disparities in mental health care for Medicaid beneficiaries lower in managed care? J Breslau, B Han, JS Levin, J Lai, H Yu Healthcare 12 (1), 100734, 2024 | | 2024 |
| Solving Psychiatric and Substance Use Disorder Treatment Bed Shortages: How Many Beds to Build and Where to Build Them RK McBain, P Gandhi, C Crowley, I Estrada-Darley, JH Cantor, ... RAND Corporation, 2024 | | 2024 |
| Methodologies to Measure Upcoding in Provider Settings JS LEVIN, DJ CRESPIN, JIN KIM, RO REID, CM WHALEY, M DWORSKY | | 2024 |
| Psychiatric and Substance Use Disorder Bed Capacity, Need, and Shortage Estimates in California: Merced, San Joaquin, and Stanislaus Counties JS Levin, JH Cantor, RK McBain, NK Eberhart, C Crowley, ... Rand Health Quarterly 10 (2), 2023 | | 2023 |
